Lotus – OTCBB: LTUS – Stock Guru ProfileOn February 15, 2007, Lotus Pharmaceuticals, Inc. announced it had completed a $3 million financing with a U.S.-based investment fund. The proceeds will be utilized to expand its domestic markets, increase sales and to acquire additional drugs for its Beijing retail stores. This is a decision that makes good business sense. China’s Ministry of Commerce Market Operations noted there will be increased consumption in health, tourism and entertainment. This projection is based on the increasing urban resident income. China’s total retail sales of consumer goods is estimated to reach CNY 8.6 trillion in 2007, a growth of about 13%, forecasts the Ministry of Commerce Market Operation Department. The sales revenue of production materials in the country is expected to increase roughly 16%. Lotus owns and operates 10 drug stores throughout many different districts of Beijing, including: ~Xin Zhong Tai Drugstore ~Long Ren Tang Drugstore ~Wan Shou Road Drugstore ~He Ping Li Drugstore ~Feng Lin Lu Zhou ~Youth Lake Drugstore ~Capital Airport Drugstore ~Young An Zhong Sheng Drugstore ~Cheng Zhuang Road Drugstore ~Feng Tai Drugstore These ten drugstores deal in both Western and traditional Chinese drinking pieces, medical treatment facilities of over 5,000 types.Lotus has a strong foundation in China. Chinese companies are typically favored over western companies. Lotus has a phenomenal pipeline and it is ready to launch major drugs. (Link here for the list.) Source: Lotus Pharmaceuticals and Chemical and Engineering News, March 2007 Lotus Pharmaceuticals, Inc. 7900 Glades Road, Suite 420 Boca Raton, Florida 33434 Phone: (877) 801-0344 Fax: (954) 337-2204 Email: info@lotuseast.com Disclosure: Pentony Enterprises LLC was compensated $10,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the company and its management. Such statements reflect management’s current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company’s ability to obtain additional financing and the demand for the Company’s products. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-look ing statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”). StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.
StockGuru Blog Live from ValueRich in Miami: Lotus Pharmaceuticals, Inc. — Financing Will Support Growth
April 28, 2007 at 8:46am
Archives
Select A Month